C. Strader

发表

Structure and function of G protein-coupled receptors.

C. Strader, T. M. Fong, M. Tota, 1994, Annual review of biochemistry.

Nonpeptidal peptidomimetics with a β-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist

Ralph Hirschmann, J. Salvino, C. Donaldson, 1992 .

De Novo Design and Synthesis of Somatostatin Non‐Peptide Peptidomimetics Utilizing β‐D‐Glucose as a Novel Scaffolding.

C. Donaldson, C. Strader, R. Freidinger, 1994 .

Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.

A B Smith, C. Strader, M. Cichy-Knight, 1996, Journal of medicinal chemistry.

IDENTIFICATION OF CRITICAL FUNCTIONAL GROUPS WITHIN BINDING POCKETS OF G-PROTEIN-COUPLED RECEPTORS

C. Strader, T. Fong, M. Cascieri, 1996 .

Functional mapping of the ligand binding sites of G‐Protein coupled receptors

C. Strader, T. Fong, T. Fong, 1994, Medicinal research reviews.

Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.

C. Strader, R. Dixon, I. Sigal, 1988, The Journal of biological chemistry.

Mutational analysis of beta-adrenergic receptor glycosylation.

C. Strader, R. Dixon, E. Rands, 1990, The Journal of biological chemistry.

Identification of Residues Essential for the Active Conformation of the ß-Adrenergic Receptor by Site-Directed Mutagenesis

C. Strader, R. Dixon, I. Sigal, 1990 .

CONFORMATION OF"THEB-ADRENERGIC RECEPTOR BY SITE-DIRECTED MUTAGENESIS

C. Strader, I. Sigal, E. Rands, 1990 .

Mapping the Functional Domains of the β-adrenergic Receptor

C. Strader, R. Dixon, I. Sigal, 1989 .

Presenilins Interact with Armadillo Proteins Including Neural‐Specific Plakophilin‐Related Protein and β‐Catenin

J. Rommens, C. Strader, P. Fraser, 1999, Journal of neurochemistry.

Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.

C. Strader, D. Underwood, C. Swain, 1994, The Journal of biological chemistry.

The role of histidine 265 in antagonist binding to the neurokinin-1 receptor.

C. Strader, D. Underwood, C. Swain, 1994, The Journal of biological chemistry.

(Thr-59)-insulin-like growth factor I stimulates 2-deoxyglucose transport in BC3H1 myocytes through the insulin-like growth factor receptor, not the insulin receptor.

C. Strader, N. Hayes, G. Chicchi, 1986, Biochimica et biophysica acta.

Differential pharmacology of cloned human and mouse B2 bradykinin receptors.

C. Strader, J. Hess, T. Macneil, 1994, Molecular pharmacology.

Antibodies to the beta-adrenergic receptor: attenuation of catecholamine-sensitive adenylate cyclase and demonstration of postsynaptic receptor localization in brain.

C. Strader, M. Caron, V. Pickel, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.

C. Strader, E. Parker, J. Hwa, 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

Isolation of a preadipocyte cell line from rat bone marrow and differentiation to adipocytes.

C. Strader, M. Cascieri, M. Candelore, 1995, Endocrinology.

Expression cloning of a human B1 bradykinin receptor.

C. Strader, J. Hess, D. Linemeyer, 1994, The Journal of biological chemistry.

Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor.

C. Strader, J. Hess, R. Ransom, 1992, Biochemical and biophysical research communications.

Cloning and pharmacological characterization of bradykinin receptors.

C. Strader, J. Hess, T. Macneil, 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Targeted Disruption of a B2 Bradykinin Receptor Gene in Mice Eliminates Bradykinin Action in Smooth Muscle and Neurons (*)

C. Strader, J. Hess, Howard Y. Chen, 1995, The Journal of Biological Chemistry.

An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria

C. Strader, T. Holland, J. MacDonald, 2018, Open forum infectious diseases.

Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.

C. Strader, T. Fong, M. Cascieri, 1992, Molecular pharmacology.

The extracellular domain of substance P (NK1) receptor comprises part of the ligand binding site.

C. Strader, T. Fong, H. Yu, 1992, Biophysical journal.

Genetic approaches to the determination of structure-function relationships of G protein-coupled receptors.

C. Strader, R. Dixon, I. Sigal, 1989, Trends in pharmacological sciences.

L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.

C. Strader, T. Bach, M. Fisher, 2000, European journal of pharmacology.

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

R. Miller, C. Strader, J. Metzger, 1998, The Journal of clinical investigation.

Topographic studies of Torpedo acetylcholine receptor subunits as a transmembrane complex.

C. Strader, M. Raftery, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins.

C. Strader, S. Blanchard, P. Hartig, 1980, The Biochemical journal.

Novel molecular targets for the treatment of obesity

C. Strader, E. Parker, J. Hwa, 1998 .

Diet-induced obese mice develop peripheral, but not central, resistance to leptin.

C. Strader, M. Graziano, E. Sybertz, 1997, The Journal of clinical investigation.

Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788.

C. Strader, J. Lachowicz, J. Clader, 2001, Life sciences.

Substituted oxazole benzenesulfonamides as potent human beta3 adrenergic receptor agonists.

C. Strader, D. Macintyre, M. Forrest, 2000, Bioorganic & medicinal chemistry letters.

Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonist

C. Strader, M. Fisher, M. Wyvratt, 1998 .

Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides.

R. Miller, C. Strader, D. Macintyre, 1999, Bioorganic & medicinal chemistry letters.

Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist.

R. Miller, C. Strader, D. Macintyre, 2000, Bioorganic & medicinal chemistry letters.

Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore.

C. Strader, M. Fisher, M. Wyvratt, 1999, Bioorganic & medicinal chemistry letters.

L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability.

R. Miller, C. Strader, D. Macintyre, 1999, Bioorganic & medicinal chemistry letters.

Molecular approaches to the discovery of new treatments for obesity.

C. Strader, D. Macintyre, E. Parker, 1997, Current opinion in chemical biology.

Characterization of a fluorescent substance P analog.

C. Strader, T. M. Fong, M. Tota, 1994, Biochemistry.

Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice.

C. Strader, M. Graziano, E. Sybertz, 1997, The American journal of physiology.

Differential Effects of Intracerebroventricular Glucagon-Like Peptide-1 on Feeding and Energy Expenditure Regulation

C. Strader, J. Hwa, L. Ghibaudi, 1998, Peptides.

Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.

C. Strader, L. Hoos, M. Graziano, 1998, Obesity research.

Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions.

C. Strader, R. Dixon, R. Diehl, 1990, Molecular Pharmacology.

Cloning and functional expression of a human glucagon-like peptide-1 receptor.

C. Strader, M. Graziano, G. Chicchi, 1993, Biochemical and biophysical research communications.

Association of sequestered beta-adrenergic receptors with the plasma membrane: a novel mechanism for receptor down regulation.

D. Sibley, C. Strader, R. Lefkowitz, 1984, Life sciences.

Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin

Brian K. Kobilka, Jeffrey L. Benovic, Henrik G. Dohlman, 1986, Nature.

LARGE-SCALE RECOMBINANT PROTEIN PRODUCTION USING THE INSECT CELLBACULOVIRUS EXPRESSION VECTOR SYSTEM: ANTISTASIN AND β-ADRENERGIC RECEPTOR

C. Strader, M. Tota, B. Junker, 1991 .

Genetic analysis of the molecular basis for β‐adrenergic receptor subtype specificity

C. Strader, R. Dixon, I. Sigal, 1989, Proteins.

Phosphorylation of the beta-adrenergic receptor in intact cells: relationship to heterologous and homologous mechanisms of adenylate cyclase desensitization.

D. Sibley, C. Strader, R. Lefkowitz, 1987, Archives of biochemistry and biophysics.

Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1990, Molecular pharmacology.

Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.

C. Strader, M. Fisher, M. Wyvratt, 1998, Bioorganic & medicinal chemistry letters.

Cloning and expression of a human glucagon receptor.

C. Strader, D. Macneil, M. Graziano, 1994, Biochemical and biophysical research communications.

Molecular biology of adrenergic receptors in the rat and frog central nervous system.

C. Strader, M. Caron, V. Pickel, 1984, Hypertension.

The GalR2 galanin receptor mediates galanin‐induced jejunal contraction, but not feeding behavior, in the rat: differentiation of central and peripheral effects of receptor subtype activation

C. Strader, M. Bayne, Suke Wang, 1998, FEBS letters.

3-Pyridyloxypropanolamine agonists of the beta 3 adrenergic receptor with improved pharmacokinetic properties.

R. Miller, C. Strader, D. Macintyre, 1998, Bioorganic & medicinal chemistry letters.

SCH 57790: a novel M2 receptor selective antagonist.

C. Strader, J. Lachowicz, J. Clader, 1999, Life sciences.

Hemocyanin linked to protein A as an immunochemical labeling reagent for electron microscopy.

C. Strader, J. Revel, M. M. Miller, 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Identification and isolation of a membrane protein necessary for leukotriene production

Jilly F. Evans, Jacques Yves Gauthier, Irving S. Sigal, 1990, Nature.

AREGU November 46/5

C. Strader, E. Parker, J. Hwa, 1999 .

Activation of the NPY Y 5 receptor regulates both feeding and energy expenditure

C. Strader, E. Parker, J. Hwa, 1999 .

Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.

C. Strader, E. Parker, J. Gao, 1999, The American journal of physiology.

Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.

C. Strader, R. Dixon, E. Rands, 1987, Molecular pharmacology.

Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.

C. Strader, M. Tota, M. Maccoss, 1997, European journal of pharmacology.

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.

C. Strader, C. Swain, B. Francés, 1992, Molecular pharmacology.

Conformational compatibility as a basis of differential affinities of tachykinins for the neurokinin-1 receptor.

C. Strader, T. M. Fong, R. Huang, 1995, Biochemistry.

1,4-Diacylpiperazine-2-(S)-[(N-aminoalkyl)carboxamides] as novel, potent substance P receptor antagonists.

C. Strader, W. Greenlee, M. Maccoss, 1993 .

Quinuclidine-based NK-1 antagonists I: 3-benzyloxy-1-azabicyclo[2.2.2]octanes

C. Strader, C. Swain, R. Baker, 1993 .

Insulin receptor desensitization correlates with attenuation of tyrosine kinase activity, but not of receptor endocytosis.

C. Strader, N. Hayes, E. Slater, 1987, The Biochemical journal.

Mapping the functional domains of the beta-adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1989, American journal of respiratory cell and molecular biology.

Identification of a specific domain in the beta-adrenergic receptor required for phorbol ester-induced inhibition of catecholamine-stimulated adenylyl cyclase.

C. Strader, R. Dixon, J. Johnson, 1990, Molecular pharmacology.

Potentiation of specific association of insulin with HepG2 cells by phorbol esters.

C. Strader, A. Blake, 1986, The Biochemical journal.

Structure-function analysis of the beta-adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1988, Cold Spring Harbor symposia on quantitative biology.

Interaction of the unique competitive inhibitor imidazole with human carbonic anhydrase B.

C. Strader, R. Khalifah, H. Wolpert, 1977, Biochemistry.

Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice

C. Strader, J. Hess, R. Heavens, 1997, Neuropharmacology.

[14] Site-directed mutagenesis

C. Strader, T. Fong, M. Candelore, 1995 .

cDNA sequence and heterologous expression of the human neurokinin-3 receptor.

C. Strader, T. M. Fong, K. Mazina, 1992, Biochemical and biophysical research communications.

Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.

C. Strader, Hongfeng Yu, T. Fong, 1992, Molecular pharmacology.

Reconstitution of beta-adrenergic receptors in lipid vesicles: affinity chromatography-purified receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system.

B. Strulovici, C. Strader, M. Caron, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Quinuclidine based NK-1 antagonists 2: determination of the absolute stereochemical requirements

C. Strader, C. Swain, R. Ball, 1993 .

2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist.

C. Strader, J. Metzger, M. Maccoss, 1996, Journal of medicinal chemistry.

1,2,3-Trisubstituted cyclohexyl substance P antagonists: Significance of the ring nitrogen in piperidine-based NK-1 receptor antagonists

C. Strader, D. Underwood, M. Maccoss, 1995 .

Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site.

C. Strader, M. Tota, C D Strader, 1990, The Journal of biological chemistry.

The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.

C. Strader, X. Yao, S. Altmann, 2002, Biochimica et biophysica acta.

Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents.

C. Strader, D. Macintyre, M. Forrest, 2000, Bioorganic & medicinal chemistry letters.

Cytoplasmic loop of β-adrenergic receptors: synaptic and intracellular localization and relation to catecholaminergic neurons in the nuclei of the solitary tracts

Virginia M. Pickel, C. Strader, C. Aoki, 1989, Brain Research.

Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

C. Strader, C. Swain, T. Fong, 1993, Nature.

Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580.

C. Strader, T. Fong, H. Yu, 1992, The Journal of biological chemistry.

Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor.

C. Strader, M. Tota, R. Dixon, 1991, Trends in pharmacological sciences.

Identification of residues involved in ligand binding to the neurokinin-2 receptor.

C. Strader, T. M. Fong, P. Vicario, 1995, Biochemistry.

The family of G‐protein‐coupled receptors

C. Strader, M. Tota, T. Fong, 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.

C. Strader, J. Lachowicz, J. Clader, 2001, Farmaco.

3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonists.

C. Strader, D. Macintyre, M. Forrest, 1998, Bioorganic & medicinal chemistry letters.

Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor.

C. Strader, M. Caron, H. Dohlman, 1988, Biochemistry.

Chapter 23. Structure and Function of G-Protein Coupled Receptors

C. Strader, R. Dixon, I. Sigal, 1988 .

Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core

Irving S. Sigal, C. Strader, R. Dixon, 1987, Nature.

Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice (*)

Margaret S. Wu, C. Strader, J. Flier, 1996, The Journal of Biological Chemistry.

Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant.

C. Strader, L. Kelly, M. Cascieri, 1996, Endocrinology.

Presenilin mutations in Alzheimer's disease: molecular models suggest a potential functional locus.

C. Strader, J. Brown, N. Murgolo, 1996, Trends in pharmacological sciences.

Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.

C. Strader, T. M. Fong, Ruey-Ruey C. Huang, 1994, Molecular pharmacology.

Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.

C. Strader, T. M. Fong, T. Fong, 1994, Biochemistry.

Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.

C. Strader, R. Dixon, I. Sigal, 1987, Nature.

Acetylcholine receptor: complex of homologous subunits.

L. Hood, M. Hunkapiller, C. Strader, 1980, Science.

Structural basis of β‐adrenergic receptor function

C. Strader, I. Sigal, I S Sigal, 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Leutropin/beta-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface.

C. Strader, W. Moyle, R. Myers, 1991, The Journal of biological chemistry.

Interaction of [125I]-alpha-bungarotoxin with acetylcholine receptor from Torpedo californica.

C. Strader, S. Blanchard, M. Schimerlik, 1979, Biochemistry.

Cloning and Expression of a Novel Neuropeptide Y Receptor*

C. Strader, N. Morin, D. Macneil, 1996, The Journal of Biological Chemistry.

Mapping the ligand binding site of the NK-1 receptor

C. Strader, T. Fong, Hong Yu, 1993, Regulatory Peptides.

Amino terminal amino acid sequence of the major polypeptide subunit of Torpedo californica acetylcholine receptor.

L. Hood, M. Hunkapiller, C. Strader, 1979, Biochemical and biophysical research communications.

Structural features required for ligand binding to the beta‐adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1987, The EMBO journal.

Identification of residues required for ligand binding to the beta-adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Molecular characterization of a common binding site for small molecules within the transmembrane domain of G-protein coupled receptors.

C. Strader, T. Fong, M. Cascieri, 1995, Journal of pharmacological and toxicological methods.

Structure-Function Analysis of the β-Adrenergic Receptor

Irving S. Sigal, C. Strader, I. Sigal, 1988 .

Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation.

C. Strader, N. Murgolo, M. Graziano, 2000, Molecular pharmacology.

Genetic Analysis of β-Adrenergic Receptor Structure and Function

C. Strader, R. Dixon, 1990 .

Molecular cloning and pharmacological characterization of a new galanin receptor subtype.

C. Strader, M. Bayne, Suke Wang, 1997, Molecular pharmacology.

Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.

C. Strader, R. Dixon, I. Sigal, 1989, The Journal of biological chemistry.

Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.

C. Strader, X. Guan, A. Amend, 1995, Molecular pharmacology.

A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists.

C. Strader, R. Dixon, I. Sigal, 1989, The Journal of biological chemistry.

Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity.

C. Strader, R. Dixon, I. Sigal, 1987, The Journal of biological chemistry.

Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor.

K Prendergast, C. Strader, D. Underwood, 1994, Chemistry & biology.

Allele-specific activation of genetically engineered receptors.

C. Strader, R. Dixon, A. Patchett, 1991, The Journal of biological chemistry.

Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.

C. Strader, M. Bayne, A. Clemmons, 1998, Biochemistry.

Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides.

C. Strader, D. Macintyre, M. Forrest, 1999, Bioorganic & medicinal chemistry letters.

Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor.

F. Monsma, C. Strader, N. Murgolo, 2002, Molecular pharmacology.

Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs.

C. Strader, A. Cheung, R. Huang, 1992, Molecular pharmacology.

Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.

C. Strader, R. Dixon, I. Sigal, 1989, Molecular pharmacology.

The carboxyl terminus of the hamster β-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration

C. Strader, R. Dixon, I. Sigal, 1987, Cell.

Purification and reconstitution of a recombinant human neurokinin-1 receptor.

C. Strader, M. Tota, K. Mazina, 1996, Journal of receptor and signal transduction research.

The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.

C. Strader, M. Graziano, C D Strader, 1996, Receptors & channels.

Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c.

C. Strader, M. Bayne, D. Weinberg, 1994, Biochemical and biophysical research communications.

Hemocyanin-protein A, an immunochemical reagent for scanning and transmission electron microscopy.

C. Strader, J. Revel, M. M. Miller, 1980, Scanning electron microscopy.

Expression and solubilization of a recombinant human neurokinin-1 receptor in insect cells.

C. Strader, K. Mazina, T. Fong, 1994, Journal of receptor research.

Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.

C. Strader, T. Fong, R. Huang, 1992, The Journal of biological chemistry.

The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides.

C. Strader, T. Fong, Hong Yu, 1992 .

The characterization of actin associated with postsynaptic membranes from Torpedo californica.

C. Strader, E. Lazarides, M. Raftery, 1980, Biochemical and biophysical research communications.

Genetic Analysis of the β-Adrenergic Receptor

C. Strader, R. Dixon, 1992 .

Mutagenesis Approaches for Elucidation of Protein Structure‐Function Relationships

C. Strader, 1998, Current protocols in neuroscience.

Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.

C. Strader, R. Dixon, J. Friedman, 1989, Molecular pharmacology.

Synthetic segments of the mammalian beta AR are preferentially recognized by cAMP-dependent protein kinase and protein kinase C.

C. Strader, E. Slater, R. Mumford, 1987, Biochemical and biophysical research communications.

Fluorescent localization of the beta-adrenergic receptor on DDT-1 cells. Down-regulation by adrenergic agonists.

C. Strader, B. Zemcik, 1988, The Biochemical journal.

Mutational analysis of neurokinin receptor function.

C. Strader, D. Underwood, C. Swain, 1995, Canadian journal of physiology and pharmacology.

Quinuclidine-based NK1 antagonists, the role of the benzhydryl

C. Strader, C. Swain, T. Fong, 1995 .

Acyclic NK1 antagonists: Replacements for the benzhydryl group.

C. Strader, C. Swain, W. S. Saari, 1994 .

Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists.

C. Strader, D. Underwood, C. Swain, 1994, The Journal of biological chemistry.

The relationship of tissue localization, distribution and turnover to feeding after intraperitoneal 125I-leptin administration to ob/ob and db/db mice.

C. Strader, L. Hoos, M. Graziano, 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice.

C. Strader, S. Boyce, J. Hess, 1996, Immunopharmacology.

Intracerebroventricular Injection of Leptin Increases Thermogenesis and Mobilizes Fat Metabolism in ob/ob Mice

C. Strader, Strader Cd, A. Fawzi, 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The extracellular domain of the neurokinin-1 receptor is required for high affinity binding of peptides

C. Strader, T. Fong, Hong Yu, 1992, Regulatory Peptides.

Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the β‐adrenergic receptor

C. Strader, A. Cheung, Michael P. Graziano, 1991, FEBS letters.

Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.

C. Strader, C. Swain, S. Mills, 1995, Molecular pharmacology.

Genomic organization and functional characterization of the mouse GalR1 galanin receptor

C. Strader, R. Burrier, M. Maguire, 1997, FEBS letters.

Discovery of L-755,507: A Subnanomolar Human β3 Adrenergic Receptor Agonist.

C. Strader, M. Wyvratt, A. Weber, 1998 .

Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange.

C. Strader, D. Barber, P. Bongiorno, 1992, Molecular pharmacology.

Interaction of [fluorescein-Trp25]Glucagon with the Human Glucagon Receptor Expressed in Drosophila Schneider 2 Cells (*)

C. Strader, M. Tota, A. Sirotina, 1995, The Journal of Biological Chemistry.

Randomized Controlled Trials of the D1/D5 Antagonist Ecopipam for Weight Loss in Obese Subjects

A. Astrup, F. Greenway, C. Strader, 2007, Obesity.

Acyclic NK-1 antagonists: 2-benzhydryl-2-aminoethyl ethers

C. Strader, C. Swain, B. Williams, 1994 .